NCMB outlined its expectations for licensees who may wish to consider or recommend new and innovative treatments for patients in a new position statement entitled, Licensee use of new or innovative treatment. Some key principles include:

* Avoiding overpromising or exaggerating benefits of the treatment;
* Balancing the need to honor patient autonomy against the need to protect patients from risks of novel treatments;
* Ensuring that treatment decisions are always made in the best interest of patients.

NCMB is grateful to all who provided feedback during the development of the new position statement.

Read the full text of the new position.